REAL-WORLD EFFECTIVENESS AND SAFETY OF RISANKIZUMAB IN ADULT PATIENTS WITH PLAQUE PSORIASIS: A 16-WEEK INTERNATIONAL MULTI-CENTER RETROSPECTIVE COHORT STUDY

被引：0
|
作者：
Bagit, Ahmed [1 ]
Maliyar, Khalad [2 ]
Mansour, Mark [2 ]
Georgakopoulos, Jorge R. [2 ]
Rankin, Brian [3 ]
Lytvyn, Yuliya [1 ,2 ]
Zaaroura, Hiba [2 ]
Park, Ye-Jean [1 ]
Wang, Emilie [3 ]
Mufti, Asfandyar [2 ,4 ]
Torres, Tiago [5 ,6 ]
Le, Ana M. [5 ]
Vender, Ronald [7 ,8 ]
Prajapati, Vimal H. [3 ,9 ,10 ,11 ,12 ,13 ]
Yeung, Jensen [2 ,3 ,14 ,15 ]
机构：
[1] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[2] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada
[3] Univ Calgary, Dept Med, Div Dermatol, Calgary, AB, Canada
[4] Sunnybrook Hlth Sci Ctr, Div Dermatol, Toronto, ON, Canada
[5] Ctr Hosp St Antonio, Dept Dermatol, Porto, Portugal
[6] Univ Porto, Inst Ciencias Biomed Abel Salazar, Porto, Portugal
[7] Dermatrials Res Inc & Venderm Consulting, Hamilton, ON, Canada
[8] Venderm Consulting, Hamilton, ON, Canada
[9] Dermatol Res Inst, Calgary, AB, Canada
[10] Prob Med Res, Calgary, AB, Canada
[11] Skin Hlth & Wellness Ctr, Calgary, AB, Canada
[12] Univ Calgary, Sect Community Pediat, Calgary, AB, Canada
[13] Sect Pediat Rheumatol, Dept Pediat, Calgary, AB, Canada
[14] Womens Coll Hosp, Div Dermatol, Toronto, ON, Canada
[15] Prob Med Res, Toronto, ON, Canada
来源：
ACTA DERMATO-VENEREOLOGICA | 2024年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P-038
引用
收藏
页数：102
相关论文
共 50 条
  • [1] Real-World Effectiveness and Safety of Risankizumab in Adult Patients with Plaque Psoriasis: A 16-Week International Multicenter Retrospective Cohort Study
    Bagit, Ahmed
    Maliyar, Khalad
    Mansour, Mark
    Georgakopoulos, Jorge R.
    Rankin, Brian D.
    Lytvyn, Yuliya
    Zaaroura, Hiba
    Park, Ye-Jean
    Wang, Ou Jia
    Mufti, Asfandyar
    Torres, Tiago
    Le, Ana M.
    Vender, Ronald
    Prajapati, Vimal H.
    Yeung, Jensen
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024, 28 (06) : 604 - 605
  • [2] REAL-WORLD EFFECTIVENESS AND SAFETY OF RISANKIZUMAB IN ADULT PATIENTS WITH PLAQUE PSORIASIS: A 1-YEAR INTERNATIONAL MULTICENTER RETROSPECTIVE COHORT STUDY
    Bagit, Ahmed
    Maliyar, Khalad
    Mansour, Mark
    Georgakopoulos, Jorge R.
    Rankin, Brian
    Lytvyn, Yuliya
    Zaaroura, Hiba
    Park, Miss Ye-Jean
    Wang, Emilie
    Mufti, Asfandyar
    Torres, Tiago
    Le, Ana M.
    Vender, Ronald
    Prajapati, Vimal H.
    Yeung, Jensen
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [3] Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 16-week multicenter retrospective study
    Rimke, Alexander
    Sood, Siddhartha
    Rankin, Brian D.
    Abduelmula, Abrahim
    Georgakopoulos, Jorge R.
    Maliyar, Khalad
    Bagit, Ahmed
    Leung, Fernejoy
    Stark, Lauren A.
    Vender, Ronald
    Yeung, Jensen
    Prajapati, Vimal H.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (02) : 359 - 361
  • [4] Effectiveness and safety of risankizumab dose optimization in adult patients with plaque psoriasis: An international multicentre retrospective cohort study
    Bagit, A.
    Maliyar, K.
    Mansour, M.
    Georgakopoulos, J. R.
    Rankin, B.
    Lytvyn, Y.
    Zaaroura, H.
    Park, Y. J.
    Wang, E.
    Mufti, A.
    Torres, T.
    Le, A. M.
    Vender, R.
    Prajapati, V. H.
    Yeung, J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
  • [5] Real-world experience with risankizumab in patients with plaque psoriasis: a retrospective study
    Mehta, M.
    O'Toole, A.
    Gooderham, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (10) : E685 - E688
  • [6] Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-23 inhibitors: a 16-week multicentre retrospective cohort study
    Sood, Siddhartha
    Rimke, Alexander
    Rankin, Brian
    Abduelmula, Abrahim
    Georgakopoulos, Jorge
    Maliyar, Khalad
    Bagit, Ahmed
    Leung, Fernejoy
    Devani, Alim
    Vender, Ronald
    Yeung, Jensen
    Prajapati, Vimal
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [7] Efficacy and safety of risankizumab for moderate-to-severe plaque psoriasis in clinical practice: A 16-week Canadian retrospective multicenter cohort study
    Lytvyn, Yuliya
    Mufti, Asfandyar
    Zaaroura, Hiba
    Sachdeva, Muskaan
    Lu, Justin D.
    Rankin, Brian D.
    Prajapati, Vimal H.
    Vender, Ronald
    Yeung, Jensen
    JAAD INTERNATIONAL, 2022, 6 : 3 - 5
  • [8] Real-world effectiveness and safety of teriflunomide in Chinese MS patients: a multi-center retrospective study
    Yang, H.
    Zhou, H.
    Bu, B.
    Quan, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 644 - 644
  • [9] Risankizumab in obese patients with moderate-to-severe plaque psoriasis: a 104-week, real-world, retrospective study
    Rompoti, Natalia
    Koumprentziotis, Ioannis-Alexios
    Stefanaki, Irene
    Vavouli, Charitomeni
    Papoutsaki, Marina
    Politou, Maria
    Panagakis, Pantelis
    Befon, Angeliki
    Kousta, Fiori
    Lazou, Eleni
    Chasapi, Vasiliki
    Stratigos, Alexander
    Nicolaidou, Electra
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (09)
  • [10] Real-World Effectiveness and Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis in Adult Patients: A 52-Week Multicenter Retrospective Study
    Yeung, Jensen
    Sood, Siddhartha
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024,
12345